Richard A Slayden Selected Research

Intraperitoneal Injections

4/2014	Time-dependent diaryl ether inhibitors of InhA: structure-activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy.
1/2014	A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard A Slayden Research Topics

Disease

15	Tuberculosis (Tuberculoses) 01/2017 - 07/2002
14	Infections 01/2022 - 11/2006
2	Communicable Diseases (Infectious Diseases) 11/2021 - 07/2016
2	Melioidosis 10/2016 - 01/2014
1	COVID-19 01/2022
1	Lung Injury 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2021
1	Osteoarthritis 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Inflammation (Inflammations) 10/2016
1	Migraine Disorders (Migraine) 10/2016
1	Fever (Fevers) 02/2011
1	Tularemia 03/2009
1	Leprosy (Hansen's Disease) 11/2006

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 01/2021 - 01/2007
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2002
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2006
3	Oxidoreductases (Dehydrogenase)IBA 12/2016 - 01/2013
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2017 - 11/2015
2	Phenyl EthersIBA 12/2016 - 01/2014
2	Acyl Carrier ProteinIBA 06/2014 - 01/2013
2	BenzimidazolesIBA 05/2014 - 01/2014
1	(11R,13S,17S)- 11- (1,3- benzodioxol- 5- yl)- 17- hydroxy- 13- methyl- 17- prop- 1- ynyl- 1,2,6,7,8,11,12,14,15,16- decahydrocyclopenta(a)phenanthren- 3- oneIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	AndrogensIBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	TriterpenesIBA 11/2021
1	betulinIBA 11/2021
1	lupaneIBA 11/2021
1	DNA Topoisomerase IV (Topoisomerase IV)IBA 10/2021
1	DNA GyraseIBA 10/2021
1	NeurotoxinsIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	ManganeseIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2018
1	isonicotinyl-NADIBA 01/2017
1	SolventsIBA 12/2016
1	LipidsIBA 12/2016
1	Dinoprostone (PGE2)FDA Link 10/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2016
1	tolfenamic acidIBA 10/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2016
1	2-hydroxypyridineIBA 06/2014
1	CG 400549IBA 06/2014
1	Ether (Diethyl Ether)IBA 04/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2013
1	EstersIBA 11/2011
1	Coenzyme A (CoA)IBA 11/2011
1	Vitamin K 2 (Vitamin K2)IBA 11/2011
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 04/2011
1	Glycoproteins (Glycoprotein)IBA 02/2011
1	Antitubercular AgentsIBA 11/2010
1	Biological ProductsIBA 05/2009
1	AerosolsIBA 04/2009
1	EnzymesIBA 03/2009
1	ElementsIBA 11/2006
1	Recombinant ProteinsIBA 11/2006
1	GlycolipidsIBA 11/2006
1	AntigensIBA 11/2006
1	Mycolic Acids (Mycolic Acid)IBA 12/2003
1	1-Butanol (n Butanol)IBA 03/2003
1	Ethambutol (Myambutol)FDA LinkGeneric 03/2003
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 03/2003
1	Oxygen (Dioxygen)IBA 07/2002
1	Peptides (Polypeptides)IBA 07/2002

Therapy/Procedure

2	Intraperitoneal Injections 04/2014 - 01/2014
2	Drug Therapy (Chemotherapy) 11/2006 - 03/2003